Can hypermethylated Wnt-antagonist genes act as biomarkers for bladder cancer?
Original article Urakami S et al. (2006) Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection. Clin Cancer Res 12: 2109–2116 PubMedDysfunction of Wnt-antagonist genes can contribute to carcinogenesis, and aberrant promoter hypermethylation of these genes has been found in bladder tumors.